Bar Pharmaceuticals S.r.l.

This is the first study testing a new drug called BAR502 in humans. Researchers will give the drug to 52 healthy volunteers to check if it's safe and see how the body processes it. The goal is to gather basic information to potentially develop a treatment for NASH, a serious live…